Lacosamide
NDC 69315-318, Lacosamide, solution, from Leading Pharma, LLC.
- Product NDC
- 69315-318
- Status
- Listed
- Labeler
- Leading Pharma, LLC
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216461
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/69315-318 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LACOSAMIDE10 mg/mL
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69315-318-20 | 69315031820 | 200 mL in 1 BOTTLE, PLASTIC (69315-318-20) |
| 69315-318-46 | 69315031846 | 465 mL in 1 BOTTLE, PLASTIC (69315-318-46) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/45786c84-51ef-4440-bc88-2501951e4c41NADAC price for package 69315031820
GET /v1/drugs/nadac/69315031820
Use it
Look up 69315-318 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69315-318 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69315-318. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.